3 July 2019 - Authorisation based on GEMINI pivotal trials in which Dovato achieved non-inferior efficacy compared to a dolutegravir-based, three-drug ...
12 September 2016 - Janssen today announced the submission of a Marketing Authorisation Application to the EMA, seeking approval for ...
22 August 2016 - Truvada is the first anti-retroviral medicine to be licensed in Europe for pre-exposure prophylaxis, in combination with ...
22 July 2016 - Truvada to enhance existing HIV prevention strategies. ...
8 July 2016 - The EMA has published an EPAR for Gilead Sciences' Odefsey. ...
23 June 2016 - Odefsey is the second single tablet regimen containing the Descovy backbone and the third product in Gilead’s ...
25 April 2016 - Gilead Sciences today announced that the European Commission has granted marketing authorization for two doses of Descovy ...
26 February 2016 - Gilead Sciences, Inc. today announced that the CHMP, the scientific committee of the EMA, has adopted a ...